Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Prostate. 2021 May 5;81(10):618–628. doi: 10.1002/pros.24136

Figure 1: Top serum metabolites and metabolic pathways altered at 3- and 6-month after initiating ADT treatments in participants receiving LCD.

Figure 1:

(A) Metabolites were selected by Volcano plot analysis of pairwise comparison between the BL vs. M3 (A) and BL vs. M6 (C) ADT. (B, D) Top enriched metabolic pathways affected by ADT after M3 (B) and M6 (D) of LCD.